The ubiquitin-binding protein p62 identifies argyrophilic grain pathology with greater sensitivity than conventional silver stains

Acta Neuropathologica

Volumn 113, Issue 4, 2007, Pages 417-420

  Scott, Ian S ^a   Lowe, James S ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Argyrophilic grain disease; Dementia; Neurodegeneration; p62; Tauopathy

Indexed keywords

PARAFFIN; PROTEIN ANTIBODY; PROTEIN P62; UBIQUITIN;

AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EMBEDDING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; SENSITIVITY ANALYSIS; SILVER STAINING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCLUSION BODIES; MALE; NEURODEGENERATIVE DISEASES; SILVER STAINING; STAINING AND LABELING;

EID: 33947248608     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-006-0165-6     Document Type: Article

References (17)

1. Botez G, Schultz C, Ghebremedhin E, Bohl J, Braak E, Braak H (2000) Clinical aspects of argyrophilic grain disease. Nervenarzt 71:38-43
2. Braak H, Braak E (1987) Argyrophilic grains: Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer's changes. Neurosci Lett 76:124-127
3. Braak H, Braak E (1998) Argyrophilic grain disease: Frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105:801-819
4. Chan K-K, Lowe JS (2002) Techniques in neuropathology. In: Bancroft JD, Gamble M (eds) Theory and practice of histological techniques, 5th edn. Churchill Livingstone, London, pp 397-398
5. Chin SS-M, Goldman EJ (1996) Glial inclusions in CNS degenerative diseases, J. Neuropathol Exp Neurol 55:499-508
6. Ding ZT, Wang Y, Jiang YP, Yoshida M, Mimuro M, Inagaki T, Iwase T, Hashizume Y (2006) Argyrophilic grain disease: Frequency and neuropathology in centenarians. Acta Neuropathol 111:320-328
7. Fujino Y, Wang DS, Thomas N, Espinoza M, Davies P, Dickson DW (2005) Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry. J Neuropathol Exp Neurol 64:209-214
8. Geetha T, Wooten MW (2002) Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett 512(1-3):19-24
9. Kuusisto E, Salminen A, Alafuzof I (2001) Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 12(10):2085-2090
10. Martinez-Lage P, Munoz DG (1997) Prevalence and disease associations of argyrophilic grains of Braak. J Neuropathol Exp Neurol 56:157-164
11. Togo T, Dickson DW (2002) Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease, Acta Neuropathol 104:398-402
12. Togo T, Isojima D, Akatsu H, Suzuki K, Uchikado H, Katsuse O, Iseki E, Kosaka K, Hirayasu Y (2005) Clinical features of argyrophilic grain disease: A retrospective survey of cases with neuropsychiatric symptoms. Am J Geriatr Psychiatry 13(12):1083-1091
13. Tolnay A, Probst A (1998) Ballooned neurons expressing α, B-crystallin as a constant feature of the amygdala in argyrophilic grain disease. Neurosci Lett 246:165-168
14. Tolnay M, Ghebremedhin E, Probst A, Braak H (2003) Argyrophilic grain disease. In: Dickson DW (ed) Teurodegeneration: the molecular pathology of dementia and movement disorders, ISN Neuropath Press, Basel, pp 132-136
15. Tolnay M, Probst A (1999) Review: Tau protein pathology in Alzheimer's disease and related disorders. Neuropathol Appl Neurobiol 25:171-187
16. Tolnay M, Spillantini MG, Goedert M, Ulrich J, Langui D, Probst A (1997) Argyrophilic grain disease: Widespread hyperphosphorylation of tau protein in limbic neurons, Acta Neuropathol 93:477-484
17. Uchihara T, Nakamura A, Mochizuki Y, Hayashi M, Orimo S, Isozaki E, Mizutani T (2005) Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: Comparison between Gallyas-Braak and Campbell-Switzer methods. Acta Neuropathol 110:255-260